Corrigendum to “Elucidating the potential benefit of pump-delivered subcutaneous GLP-1R agonist: an exploratory study in the diet-induced obese mouse” [Obes. Med. 59, (2026), 100681]
Corrigendum to “Elucidating the potential benefit of pump-delivered subcutaneous GLP-1R agonist: an exploratory study in the diet-induced obese mouse” [Obes. Med. 59, (2026), 100681]. // Obesity Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2451847626000679?dgcid=rss_sd_all
Corrigendum to “Elucidating the potential benefit of pump-delivered subcutaneous GLP-1R agonist: an exploratory study in the diet-induced obese mouse” [Obes. Med. 59, (2026), 100681]. Obesity Medicine. https://www.sciencedirect.com/science/article/pii/S2451847626000679?dgcid=rss_sd_all
“Corrigendum to “Elucidating the potential benefit of pump-delivered subcutaneous GLP-1R agonist: an exploratory study in the diet-induced obese mouse” [Obes. Med. 59, (2026), 100681].” Obesity Medicine.
@article{article60647,
title = {Corrigendum to “Elucidating the potential benefit of pump-delivered subcutaneous GLP-1R agonist: an exploratory study in the diet-induced obese mouse” [Obes. Med. 59, (2026), 100681]},
journal = {Obesity Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2451847626000679?dgcid=rss_sd_all}
}